<DOC>
	<DOCNO>NCT01775072</DOCNO>
	<brief_summary>The purpose study determine whether certain gene cancer may abnormal . When gene abnormal call mutation . Most mutation cancer cell inherit ( pass parent ) happen birth cancer . Most cancer many mutation . Some mutation important cancer cell survive others . The goal study test cancer certain mutation use leftover tumor tissue previous surgery biopsy . Participants also ask provide tube blood cheek ( also know buccal ) swab , saliva sample contains normal gene comparison . The purpose Part B study : Understand genetic change tumor effect chance respond experimental cancer treatment . Understand gene tumor change overtime response target cancer treatment .</brief_summary>
	<brief_title>Genomic Profiling Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>Part A : Patients cancer relate disorder Part B : Patients successfully register Part A ( MSKCC IRB # 12245 ) Prior write approval patient consent obtain Director Center fo Molecular Oncology , Principal/CoPrincipal Investigator MSKCC IRB # 12245 . Part C : Patient must receive ongoing care MSK . Treatment MSK Alliance Site qualify . Patient must successfully consent Part A study . Unwilling unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>tissue</keyword>
	<keyword>blood</keyword>
	<keyword>salvia</keyword>
	<keyword>buccal swab</keyword>
	<keyword>Genomic Profiling</keyword>
	<keyword>Solid Tumors</keyword>
	<keyword>hematologic cancer</keyword>
	<keyword>Clinical Assay</keyword>
	<keyword>Research Assay</keyword>
	<keyword>12-245</keyword>
</DOC>